Abstract
Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Current Pharmaceutical Biotechnology
Title:Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure
Volume: 13 Issue: 10
Author(s): M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue
Affiliation:
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Abstract: Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Export Options
About this article
Cite this article as:
D. Schwartz M., G. Hurst C., A. Kirk M., J.D. Reedy S. and H. Braue E., Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure, Current Pharmaceutical Biotechnology 2012; 13 (10) . https://dx.doi.org/10.2174/138920112802273191
DOI https://dx.doi.org/10.2174/138920112802273191 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Risk Factors for Heart Failure Progression and Outcomes
Current Cardiology Reviews Contribution of Ultrasonography of Hands and Wrists in Early Rheumatoid Arthritis
Current Rheumatology Reviews Cerebral Small Vessel Disease is Associated with Genetic Variations in CYP2J
Current Neurovascular Research Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype
Current Cancer Drug Targets Hypoxia-Inducible Factor-1 in Arterial Disease: A Putative Therapeutic Target
Current Vascular Pharmacology Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Analysis of Chemical Composition by GC-MS and In-vitro Antidiabetic Activity of Azadirachta Indica Leaves Collected from Erbil, Iraq
Current Traditional Medicine Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
Current Medicinal Chemistry Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Structure-activity Relationships of Snake Toxins Targeting Platelet Receptors, Glycoprotein Ib-IX-V and Glycoprotein VI
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Halogenated Derivatives of Aromatic Amino Acids Exhibit Balanced Antiglutamatergic Actions: Potential Applications for the Treatment of Neurological and Neuropsychiatric Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Peptide modules for overcoming barriers of nucleic acids transport to cells
Current Topics in Medicinal Chemistry Post-Stroke Immunodepression and Infection: An Emerging Concept
Infectious Disorders - Drug Targets Antioxidant Activities and Total Phenolics Contents from Extracts of Terminalia catappa, Carrisa carandas, and Opuntia ficus indica Fruits
Recent Innovations in Chemical Engineering One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Personalized Medicine in Psoriasis: Concept and Applications
Current Vascular Pharmacology Nicotinamide and its Pharmacological Properties for Clinical Therapy
Drug Design Reviews - Online (Discontinued) Meet Our Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulation of Cellular Mg2+ Content in Cardiac Cells by α1-Adrenoceptor Stimulation and Anti-Arrhythmic Agents
Recent Patents on Biotechnology